Categories
Popular Articles

MacroGenics And Lilly Achieve Targeted Patient Enrollment In PROTEGE, A Global Phase 2/3 Clinical Trial Of Teplizumab In Type 1 Diabetes
MacroGenics, Inc. and Eli Lilly and Company (NYSE: LLY) announced that the PROTEGE trial achieved its targeted patient enrollment. The trial is a pivotal Phase 2/3 clinical study evaluating teplizumab, an investigational compound under development for the treatment of individuals with recent-onset type 1 diabetes.
new payday loan lenders
Buy zoloft and forget about depression.
Surveys Show GPs Need More Support - Australian Medical Association
A study which found up to one third of GPs are planning to retire early highlights the need for governments to boost support for general practice, AMA Federal President, Dr Andrew Pesce, said today.
News of the day
Pitt Study Redefines Binge Drinking For Children And Adolescents
The criteria used to assess blood alcohol concentrations (BACs) and binge drinking behaviors in children and adolescents should be based on pediatric rather than adult physiology, according to a new University of Pittsburgh study in the June issue of Pediatrics.
Medical Devices

HHS Rescinds Controversial Medicaid Regulations

The Health and Human Services Department Monday "rescinded three controversial Bush administration regulations governing Medicaid and said it would postpone and possibly change or rescind a fourth," according to CQ Politics. Democrats had been particularly critical of the regulations, which had upset health care providers, state governments and advocates for the poor, and the decision to rescind them was not unexpected. CQ Politics reports: "Critics charged that the [Bush] administration was trying to shift to the states, from the federal government, the burden for about $19.6 billion in Medicaid spending over five years. Medicaid, a health insurance entitlement program for the poor, is a shared federal-state program, and there is constant tension between the two over costs" (Wayne, 6/29). Modern Healthcare also reports: "Specifically, the Obama administration will be rescinding all or part of three Medicaid regulations that were previously issued. The rulemakings in total would have eliminated reimbursement for school-based administrative and transportation costs; limited the outpatient hospital and clinic service benefit for Medicaid; and restricted beneficiary access to case management services. The CMS also plans to delay until June 30, 2010, parts of a regulation that clarified limitations on healthcare-related tax programs, to determine whether states need additional clarification or guidance. A moratorium for most of the regulations had been set to expire on July 1, under a provision set by the American Recovery and Reinvestment Act of 2009" (Lubell, 6/29). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):